MedGenome and Twist Bioscience Team up to diagnose rare diseases

MedGenome, a prominent worldwide genomics-focused diagnostics and research services company, is joining forces with Twist Bioscience, a fast-growing synthetic biology and genomics company in the US, to create the HOPE for Rare Diseases Programme in India. In the program, economically disadvantaged families can receive discounted whole exome sequencing if they provide the required documentation. The program has a limited duration.

The partnership aligns with MedGenome's celebration of ten years of leading genomics breakthroughs in India. Through this collaboration, MedGenome is restating its dedication to providing accessible and cost-effective genetic solutions to all segments of the population. MedGenome will keep following its vision to improve healthcare affordability and accessibility, and will concentrate on using genomics to tackle the significant demand in emerging markets.

Twist Bioscience is utilizing the Twist Exome 2.0 in order to assist with this goal. Created to help scientists identify uncommon genetic diseases and inherited cancers, assisting them in gathering high-quality data through reduced sequencing requirements.

The collaboration between MedGenome and Twist Bioscience aims to make this technology accessible to people in low-income communities worldwide, offering the necessary genetic information to solve their diagnostic challenges and support healthcare providers in addressing the disease.

Despite being accessible for more than ten years, this technology has not become widely used because of its expense, lack of awareness, and absence of insurance coverage, as healthcare in India still requires direct payment.